These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Prevention and treatment of malignant syndrome in Parkinson's disease: a consensus statement of the malignant syndrome research group. Ikebe S; Harada T; Hashimoto T; Kanazawa I; Kuno S; Mizuno Y; Mizuta E; Murata M; Nagatsu T; Nakamura S; Takubo H; Yanagisawa N; Narabayashi H Parkinsonism Relat Disord; 2003 Apr; 9 Suppl 1():S47-9. PubMed ID: 12735915 [TBL] [Abstract][Full Text] [Related]
8. Neuroleptic malignant syndrome in a patient with Parkinson's disease: a case study. Ward C J Neurosci Nurs; 2005 Jun; 37(3):160-2. PubMed ID: 16001822 [TBL] [Abstract][Full Text] [Related]
9. Neuroleptic malignant syndrome without neuroleptics. Ong KC; Chew EL; Ong YY Singapore Med J; 2001 Feb; 42(2):85-8. PubMed ID: 11358199 [TBL] [Abstract][Full Text] [Related]
10. An interaction between levodopa and enteral nutrition resulting in neuroleptic malignant-like syndrome and prolonged ICU stay. Bonnici A; Ruiner CE; St-Laurent L; Hornstein D Ann Pharmacother; 2010 Sep; 44(9):1504-7. PubMed ID: 20628041 [TBL] [Abstract][Full Text] [Related]